MAPT and Alzheimer disease: Alzheimer’s disease (AD) comes along with a severe cognitive decline and is characterized by the extracellular deposition of beta-amyloid (Aβ) plaques, intraneuronal Tau pathology, synaptic loss resulting in cholinergic neuronal cell death and inflammatory processes such as the activation of astrocytes and microglia (Selkoe, 2001).